secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vireo Growth Inc. (VREOF)
CIK:        0001771706
Form:       8-K
Filed at:   2026-08-11T11:11:16+00:00
Accession:  0001104659-26-093723
Event type: earnings
Sentiment:  positive
Materiality: 0.90
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Vireo Q2 GAAP revenue $209.3M up 335% YoY; proforma $254.9M; ~270 dispensaries
------------------------------------------------------------------------------

- Q2 GAAP revenue $209.3M (+335% YoY); gross profit $95.3M (45.5% margin); adjusted EBITDA $41.5M (19.8% margin).
- Proforma revenue $254.9M reflects Hawthorne, Bridgewell, PharmaCann deals; closed Hawthorne, Eaze, Bridgewell in Q2.
- Post-Q2: closed PharmaCann; announced FLUENT, C21, Planet 13 merger, Cannabist asset purchase, and Ohio vertical.
- New ABL facility: $65M initial, expandable to $105M at SOFR+1.75%-2.00%; Q2 cash $122.7M.
- Company expects to become largest U.S. cannabis operator by dispensary count with approximately 270 stores.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1771706/000110465926093723/0001104659-26-093723-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1771706/000110465926093723/vreof-20260811x8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-093723

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer